Court restricts abortion access across U.S. by blocking the mailing of mifepristone
Summary
A federal appeals court in New Orleans has ruled that the abortion pill mifepristone cannot be mailed and must be given to patients in person at clinics. This decision limits access to abortion medication across the U.S.Key Facts
- The 5th U.S. Circuit Court of Appeals made the decision.
- Mifepristone is a commonly used medicine for abortion.
- The court ruling blocks mailing the pill and requires in-person distribution.
- The decision affects abortion access nationwide.
- The court referenced Louisiana's law that considers unborn children as legal persons from conception.
- The ruling says the FDA’s previous actions on abortion pills conflict with Louisiana’s abortion ban policies.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.